Pharma Sessions

Pharma Sessions

Download on the App Store

Pharma Sessions episodes

  • Building AI Workflows That Actually Work in Pharma with Adam Mico
    Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proofing really looks like when AI lowers the barrier to building dashboards, writing code, and generating insights.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    35 min
  • Why Drug Launches Are Won Years Before Approval with Ana Bozas
    Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.

    What You’ll Learn:

    • What medical affairs and scientific communications must do years before launch
    • How publication planning determines whether launch data actually exists in the market
    • What changes and what doesn’t across different diseases, patient populations, and audiences
    • How to map all stakeholders involved in a patient’s journey
    • Why payers evaluate drugs based on population impact and proven outcomes

    Ana Bozas is a Medical Affairs and Scientific Communications leader with vast experience across rare diseases and biopharma. She currently serves as Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, supporting clinical strategy in kidney disease as the organization prepares for a pivotal regulatory moment. Previously, Ana led scientific publications and medical communications at Ipsen, with roles at Pear Therapeutics, Ionis, Sanofi, and Akebia, giving her a unique perspective across startups and established organizations during high-stakes launch periods.

    Episode Highlights
    • [00:00] Introduction
    • [03:20] Why Are Careers in Pharma Rarely Linear?
    • [04:26] How Ana Adapts Launch Strategy From Company to Company
    • [06:45] What Changes and What Never Does in Healthcare Communication
    • [10:18] How Payers Decide What Gets Funded
    • [11:38] Why Is Unpublished Data Invisible to the Market?
    • [12:53] The Productive Tension Between Marketing and Medicine
    • [14:09] How Meeting Forecasts Defines Successful Launches
    • [18:13] Medical Planning Starts 5+ Years Before Launch
    • [21:54] Why Publication Timelines Must Be Built Into Launch Plans
    • [23:39] What Medical Can and Cannot Fix at the Eleventh Hour
    • [26:32] Engaging Clinicians and Patients Early
    • [31:04] One Practical Launch Action You Can Take Tomorrow

    Episode Resources:
    • Ana Bozas on LinkedIn: https://www.linkedin.com/in/abozas/ 
    • Vera Therapeutics Website: https://veratx.com/ 
    • Jonathan Kaskey on LinkedIn: https://www.linkedin.com/in/jonkaskey/ 
    • XSUNT Corporation Website: http://www.xsunt.com/ 

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.comPharma Sessions is handcrafted by our friends over at: fame.so
    34 min
  • Why AI Pilots Fail in Pharma, And Why Yours Won’t with Jeremy Zhang
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    35 min
  • Medical Affairs AI & Omnichannel Strategy: How to Earn Trust and Attention
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs' needs through omnichannel communication strategies, accessible and engaging scientific data, and technology-enabled solutions like digital microsites and AI analysis.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    35 min
  • Sales Leadership Mastery: People + Tech
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great selling and sustainable revenue growth.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    31 min
  • Scientific Storytelling and Omnichannel Strategy in Modern Medical Affairs
    In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications & Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnichannel strategy to amplify impact, and help brands stand out in highly competitive markets.\

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    29 min
  • New Direction: Career Pivots, Niche AI, and the Future of Pharma Sessions
    In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all.
    Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driving force behind his next chapter. Along the way, he reflects on what AI should be doing in pharma, why niche, domain-specific tools outperform generic platforms, and how teams can move beyond manual reporting toward real strategic impact.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    19 min
  • Martin McLaughlin’s Four-Pillar Playbook to Launching Better, Faster, and Smarter
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    31 min
  • What Happens When Pharma Starts Listening?
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    29 min
  • How Shionogi's VP Turns Data into Commercial Success
    In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    33 min

About Pharma Sessions

From the publisher's feed

Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)

More shows like Pharma Sessions

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

31,952 Listeners

HBR IdeaCast by Harvard Business Review

HBR IdeaCast

132 Listeners

The Daily by The New York Times

The Daily

112,250 Listeners

The Readout Loud by STAT

The Readout Loud

338 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

62 Listeners